A Two-Stage Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Ec-18 in Altering the Severity and Course of Oral Mucositis Secondary to Chemoradiation Therapy for Squamous Cell Cancers of the Head and Neck

Publication Date

2025

Content Type

Article

PubMed ID:

40427161

Additional Authors:

Additional authors and institutional affiliations

This document is currently not available here.

Share

COinS